The tweet was deleted by the author.
But we saved everything 🙂.
Olema Pharmaceuticals concluded its participation at ASCO26 in Chicago, signaling renewed energy from advancements in cancer science and innovation.
The annual meeting, a renowned event for oncology professionals, inspired the company to extend an invitation to those driven by a sense of purpose to join its mission of improving outcomes for people living with cancer. Olema Pharmaceuticals emphasized the power of connections and collaborative progress in transforming the future of cancer care.
Olema Pharmaceuticals presented an OPERA-02 trial-in-progress poster at the ASCO Annual Meeting in Chicago. The company also shared findings from its OP-3136 and OPERA-02 posters during ASCO26. Both presentations focused on advancing breast cancer and cancer research, respectively.